iBio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.47 | -$0.47 | -$0.47 |
| Q2 2024 | 1 | -$0.46 | -$0.46 | -$0.46 |
| Q3 2024 | 1 | -$0.45 | -$0.45 | -$0.45 |
| Q1 2025 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q2 2025 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q3 2025 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q4 2025 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q1 2026 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q2 2026 | 1 | -$0.24 | -$0.24 | -$0.24 |
iBio, Inc. Earnings Date And Information
iBio, Inc. last posted its earnings results on Wednesday, September 25th, 2024. The company reported $-0.91 earnings per share for the quarter, missing analysts' consensus estimates of $-0.47 by $0.44. The company had revenue of 175,000 for the quarter and had revenue of 225,000 for the year. iBio, Inc. has generated $-7 earnings per share over the last year ($-6.5 diluted earnings per share) and currently has a price-to-earnings ratio of -0.39. iBio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
iBio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/24/2024 | Q4 2024 | -$2.03 | $175,000 | $175,000 | ||
| 05/13/2024 | Q3 2024 | -$0.85 | $0 | |||
| 02/09/2024 | Q2 2024 | -$4.42 | $0 | |||
| 09/29/2023 | Q1 2024 | -$4.79 | $50,000 | |||
| 09/27/2023 | Q4 2023 | -$0.41 | -$7.01 | -6.6 | $200,000 | $0 |
| 05/15/2023 | Q3 2023 | -$9.58 | $0 | |||
| 05/19/2023 | Q2 2023 | -$68.43 | $0 | |||
| 11/14/2022 | Q1 2023 | -$1.85 | -$41.01 | -39.16 | $600,000 | $0 |
| 10/11/2022 | Q4 2022 | -$2.12 | -$87.45 | -85.33 | $250,000 | $61,000 |
| 05/12/2022 | Q3 2022 | -$1.25 | -$28.90 | -27.65 | $1.94 M | |
| 02/14/2022 | Q2 2022 | -$1.00 | -$27.43 | -26.43 | $168,000 | |
| 11/15/2021 | Q1 2022 | -$1.25 | -$20.51 | -19.26 | $500,000 | $211,000 |
| 09/28/2021 | Q4 2021 | $0.27 | $800,000 | $491,000 | ||
| 05/17/2021 | Q3 2021 | -$1.25 | -$17.77 | -16.52 | $765,000 | |
| 02/16/2021 | Q2 2021 | -$1.00 | -$21.61 | -20.61 | $705,000 | |
| 11/16/2020 | Q1 2021 | -$2.00 | -$23.19 | -21.19 | $100,000 | $410,000 |
| 10/13/2020 | Q4 2020 | -$16.06 | $100,000 | $1.12 M | ||
| 05/15/2020 | Q3 2020 | -$29.26 | $96,000 | |||
| 02/13/2020 | Q2 2020 | -$50.95 | $314,000 | |||
| 11/14/2019 | Q1 2020 | -$17.89 | $108,000 |
iBio, Inc. Earnings: Frequently Asked Questions
-
When is iBio, Inc.'s earnings date?
iBio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
How can I listen to iBio, Inc.'s earnings conference call?
The conference call for iBio, Inc.'s latest earnings report can be listened to online.
-
How can I read iBio, Inc.'s conference call transcript?
The conference call transcript for iBio, Inc.'s latest earnings report can be read online.
-
How much revenue does iBio, Inc. generate each year?
iBio, Inc. (:IBIO) has a recorded annual revenue of $225,000.
-
How much profit does iBio, Inc. generate each year?
iBio, Inc. (:IBIO) has a recorded net income of $225,000. iBio, Inc. has generated $-6.5 earnings per share over the last four quarters.
-
What is iBio, Inc.'s price-to-earnings ratio?
iBio, Inc. (:IBIO) has a price-to-earnings ratio of -0.39 and price/earnings-to-growth ratio is -0.02.
